| Neuraxpharm Switzerland AG - Levetiracetam-Neuraxpharm 500 mg, Filmtabletten | | 69225 | | 02 | | Levetiracetam-Neuraxpharm 500 mg | | Filmtabletten | | N03AX14 | | Levetiracetam | | 30.08.2024 | | |
| | Composition | | levetiracetamum 500 mg, carmellosum natricum conexum corresp. natrium 2.385 mg, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Levetiracetame | 500 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| |
|
